Publications by authors named "Anna Sipos"

Claim this Profile
L
Lasting Complete Clinical Response of a Recurring Cutaneous Squamous Cell Carcinoma With Mutation and Amplification Achieved by Dual Trametinib and Metformin Therapy.
Éva Remenár, Róbert Dóczi, Anna Dirner, Anna Sipos, Anita Perjési

JCO Precis Oncol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and development of extreme selective inhibitors of the ITD and D835Y mutant FLT3 kinases.
Ferenc Baska, Anna Sipos, Zoltán Őrfi, Zoltán Nemes, Judit Dobos

Eur J Med Chem· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted drug combination therapy design based on driver genes.
Lilian Zsákai, Anna Sipos, Judit Dobos, Dániel Erős, Csaba Szántai-Kis

Oncotarget· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel compounds with potent CDK9 inhibitory activity for the treatment of myeloma.
Zsófia Czudor, Mária Balogh, Péter Bánhegyi, Sándor Boros, Nóra Breza, Anna Sipos

Bioorg Med Chem Lett· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells.
Rita Garamvölgyi, Judit Dobos, Anna Sipos, Sándor Boros, Eszter Illyés

Eur J Med Chem· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lead selection and characterization of antitubercular compounds using the Nested Chemical Library.
Anna Sipos, János Pató, Rita Székely, Ruben C Hartkoorn, László Kékesi

Tuberculosis (Edinb)· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Pyrido[2,3-b]pyrazines inhibiting both erlotinib-sensitive and erlotinib-resistant cell lines, and their preparation via regioselective condensation reaction].
László Kékesi, Anna Sipos, Gábor Németh, András Dancsó, Eszter Illyés

Acta Pharm Hung· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of phosphorus containing, specific CDK9/CycT1 inhibitors.
Gábor Németh, Zoltán Greff, Anna Sipos, Zoltán Varga, Rita Székely

J Med Chem· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological evaluation of novel pyrido[2,3-b]pyrazines inhibiting both erlotinib-sensitive and erlotinib-resistant cell lines.
László Kékesi, Anna Sipos, Gábor Németh, János Pató, Nóra Breza

Bioorg Med Chem Lett· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis